Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Fresenius Medical Care Earnings, Revenue beat In Q4

Published 2022/02/22, 13:48
FMEG
-
FREG
-
FMS
-

Investing.com - Fresenius Medical Care reported on Tuesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Fresenius Medical Care announced earnings per share of €0.9 on revenue of €4.65B. Analysts polled by Investing.com anticipated EPS of €0.8755 on revenue of €4.58B.

Fresenius Medical Care shares are up 6% from the beginning of the year and are trading at €61.000 , down-from-52-week-high.They are outperforming the STOXX 600 which is down 6.81% from the start of the year.

Fresenius Medical Care shares gained 3.67% in intra-day trade the report.

Fresenius Medical Care follows other major Healthcare sector earnings this month

Fresenius Medical Care's report follows an earnings beat by Siemens Healthineers on Thursday, February 3, 2022, who reported EPS of €0.55 on revenue of €5.07B, compared to forecasts EPS of €0.505 on revenue of €4.9B.

Sartorius AG VZO had matched expectations on Thursday, January 27, 2022 with fourth quarter EPS of €2.14 on revenue of €922.3M (NYSE:MMM), compared to forecast for EPS of €2.14 on revenue of €922.36M.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.